VCM
PRCT icon

Voleon Capital Management’s Procept Biorobotics PRCT Stock Holding History

Voleon Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
60,095
-5,064
-8% -$127K 0.02% 415
2026
Q1 		$1.63M Buy
65,159
+24,301
+59% +$685K 0.04% 362
2025
Q4 		$1.29M Buy
40,858
+34,246
+518% +$1.14M 0.03% 397
2025
Q3 		$236K Buy
+6,612
New +$302K 0.01% 786

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Voleon Capital Management's PRCT Position: Q2 2026 in Review

Voleon Capital Management reduced its Procept Biorobotics (PRCT) stake by 7.8% in Q2 2026, selling an estimated $127K and leaving 60,095 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #415.

Voleon Capital Management first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.63M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Voleon Capital Management held 60,095 shares of Procept Biorobotics worth $1.36M as of Q2 2026.
  • Voleon Capital Management sold 5,064 Procept Biorobotics shares in Q2 2026, an estimated $127K.
  • Procept Biorobotics made up 0.02% of Voleon Capital Management's portfolio in Q2 2026, its #415 holding.
  • Voleon Capital Management first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Procept Biorobotics position peaked at $1.63M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.